DUBLIN., Vasorum Ltd. The developer and manufacturer of the novel Celt ACD® vascular closure device has received approval of its PMA application from the US Food and Drug Administration (FDA). Celt ...
CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...
Irish devicemaker Vasorum got FDA approval for its Celt ADC vascular closure device that is aimed at arterial puncture closure. The device is indicated for both diagnostic and anticoagulated ...
Vasorum Ltd. announced that its vascular closure device has been approved by the FDA for use in interventional cardiology and interventional radiology procedures. The device (Celt ACD) is indicated ...
HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better outcomes than manual compression, their use appears appropriate in most procedures with ...
(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider Highlights the Growth of the U.S. Vascular Closure Devices Market-Expected to Surpass USD 0.84 Billion by 2032 Amid Increasing Cardiovascular Interventions ...
WASHINGTON, DC — A large study testing two different vascular-closure devices suggests that they are as good as manual compression for reducing vascular-site complications among patients undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback